Anne‐Geneviève Marcelin

15.6k citations

364 papers · 8.8k indexed · 1 hit paper · h-index 49

Virology top 0.05%
- HIV Research and Treatment 235
Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 225
- HIV/AIDS Research and Interventions 147
- SARS-CoV-2 and COVID-19 Research 28
Emergency Medicine top 0.5%
Hepatology top 2%
- Hepatitis C virus research 25
Epidemiology top 1%
- Cytomegalovirus and herpesvirus research 43
Oncology
- Viral-associated cancers and disorders 48
Molecular Biology
- Biochemical and Molecular Research 30

Co-authors: Vincent Cálvez Christine Katlama Marc Wirden Gilles Peytavin Isabelle Malet Cathia Soulié Roland Tubiana Dominique Costagliola
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: Nucleic Acids Research (1 paper)Angewandte Chemie International Edition (1 paper)The Journal of Experimental Medicine (1 paper)
Partner nations: France United States United Kingdom

In The Last Decade

Anne‐Geneviève Marcelin

351 papers receiving 8.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Anne‐Geneviève Marcelin

Since Specialization

Citations

This map shows the geographic impact of Anne‐Geneviève Marcelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Geneviève Marcelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Geneviève Marcelin more than expected).

Fields of papers citing papers by Anne‐Geneviève Marcelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Geneviève Marcelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Geneviève Marcelin. The network helps show where Anne‐Geneviève Marcelin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anne‐Geneviève Marcelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne‐Geneviève Marcelin Line = papers co-authored together Anne‐Geneviève Marcelin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions Open Forum Infectious Diseases ·Anna María Geretti,Marta Boffito,Stefano Bonora,Patrick Braun,Charlotte Charpentier,Féderico García,Jade Ghosn,Perpétua Gómes,Anne‐Geneviève Marcelin,Thibault Mésplède,Miłosz Parczewski,Kyle Ring,Maria Mercedes Santoro,Caroline Solas,Eva Wolf,Chloe Orkin	2025	2
2	A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia Infectious Diseases Now ·Sophie Seang,P Detruchis,Ève Todesco,M.A. Valantin,L Schneider,Romain Palich,Gilles Peytavin,Valérie Pourcher,Anne‐Geneviève Marcelin,Christine Katlama	2024	1
3	Dynamics of SARS-CoV-2 variants in West Africa: Insights into genomic surveillance in resource-constrained settings Infection Genetics and Evolution ·Josué Togo,Anou M. Somboro,Oumar Dolo,Fatoumata Tata Traoré,Ibréhima Guindo,Djeneba Fofana,Ève Todesco,Anne‐Geneviève Marcelin,Vincent Cálvez,Jane L. Holl,Robert L. Murphy,Christophe Rodriguez,Mamoudou Maïga,Almoustapha Issiaka Maiga	2024	1
4	A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import EMBO Molecular Medicine ·Aude Boulay,Emmanuel Quevarec,Isabelle Malet,Giuseppe Nicastro,Célia Chamontin,S.D. Perrin,Corinne Henriquet,Martine Pugnière,Valérie Courgnaud,Mickaël Blaise,Anne‐Geneviève Marcelin,Ian A. Taylor,Laurent Chaloin,Nathalie J. Arhel	2024	2
5	Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study Viruses ·Karen Zafilaza,Jonathan Bellet,Aurélie Truffot,Vincent Foulongne,Manuela Mireille Onambele,Maud Salmona,Camille Vellas,Claire Périllaud-Dubois,Audrey Mirand,Elisabeth André‐Garnier,Enagnon Kazali Alidjinou,Ségolène Brichler,Honorine Fenaux,Magali Bouvier‐Alias,Cédric Hartard,Céline Dorival,Fabrice Carrat,Anne‐Geneviève Marcelin,Karl Stéfic,Cathia Soulié	2024	0
6	Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization European Journal of Neurology ·Céline Louapre,Lisa Belin,Stéphane Marot,Amandine Hippolyte,Édouard Januel,Michella Ibrahim,Lina Jeantin,Karen Zafilaza,Isabelle Malet,Fanny Charbonnier‐Beaupel,Michèlle Rosenzwajg,Cathia Soulié,Anne‐Geneviève Marcelin,Valérie Pourcher	2023	1
7	A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study Biomedicines ·P. Grange,Guillaume Ollagnier,Laurianne Beauvais Remigereau,Carole Nicco,Constance Mayslich,Anne‐Geneviève Marcelin,Vincent Cálvez,N. Dupin	2022	4
8	Human Herpesvirus 8 seroprevalence among blood donors in Mali Journal of Medical Virology ·Gervillien Arnold Malonga,Sidi Dienta,Fatoumata Tata Traoré,Zalihatou Maiga,Alhassane Ba,Ousmane Faye,Elodie Chicaud,Stéphane Marot,Vincent Cálvez,Anne‐Geneviève Marcelin,Aude Jary,Almoustapha Issiaka Maïga	2022	2
9	Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi’s Sarcoma Treatment Cancers ·Adélie Gothland,Valentin Leducq,P. Grange,Ousmane Faye,Laurianne Beauvais Remigereau,Sophie Sayon,Nathalie Désiré,Aude Jary,Emmanuel Laplantine,Almoustapha Issiaka Maïga,N. Dupin,Anne‐Geneviève Marcelin,Vincent Cálvez	2022	2
10	Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers Clinical Infectious Diseases ·Stéphane Marot,Isabelle Malet,Valentin Leducq,Basma Abdi,Elisa Teyssou,Cathia Soulié,Marc Wirden,Christophe Rodriguez,Slim Fourati,Jean–Michel Pawlotsky,David Boutolleau,Sonia Burrel,Vincent Cálvez,Anne‐Geneviève Marcelin,Aude Jary	2021	9
11	Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients Journal of Antimicrobial Chemotherapy ·Romain Palich,Basma Abdi,Marc Wirden,Panagiota Lourida,Roland Tubiana,Antoine Fayçal,Marc‐Antoine Valantin,Luminita Schneider,Sophie Seang,Rachid Agher,Anne Simon,Cathia Soulié,Minh Lê,Gilles Peytavin,Vincent Cálvez,Anne‐Geneviève Marcelin,Christine Katlama	2021	1
12	Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients The Journal of Infectious Diseases ·Romain Palich,Elisa Teyssou,Sophie Sayon,Basma Abdi,Cathia Soulié,Lise Cuzin,Roland Tubiana,Marc‐Antoine Valantin,Luminita Schneider,Sophie Seang,Marc Wirden,Valérie Pourcher,Christine Katlama,Vincent Cálvez,Anne‐Geneviève Marcelin	2021	12
13	Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU American Journal of Respiratory and Critical Care Medicine ·Arnaud Fekkar,Alexandre Lampros,Julien Mayaux,Corentin Poignon,Sophie Demeret,Jean‐Michel Constantin,Anne‐Geneviève Marcelin,Antoine Monsel,Charles‐Édouard Luyt,Marion Blaize	2020	112
14	Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects? AIDS ·Baptiste Abbar,Marine Baron,Christine Katlama,Anne‐Geneviève Marcelin,Marianne Veyri,Brigitte Autran,Amélie Guihot,Jean‐Philippe Spano	2019	24
15	Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies Clinical Infectious Diseases ·Sidonie Lambert-Niclot,Maxime Grudé,Jean‐Luc Meynard,Anne‐Geneviève Marcelin,Marc‐Antoine Valantin,Philippe Flandre,Jacques Izopet,Laëtitia Moinot,Vincent Bouteloup,Vincent Cálvez,Christine Katlama,Pierre‐Marie Girard,Laurence Morand‐Joubert	2018	3
16	Efficacy of protease inhibitor monotherapy vs . triple therapy: meta‐analysis of data from 2303 patients in 13 randomized trials HIV Medicine ·José Ramón Arribas,PM Girard,Nicholas I. Paton,Alan Winston,Anne‐Geneviève Marcelin,Daniel Elbirt,Andrew Hill,M. B. Hadacek	2015	40
17	Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B Journal of Antimicrobial Chemotherapy ·Djeneba Fofana,Cathia Soulié,Almoustapha Issiaka Maïga,Slim Fourati,Isabelle Malet,Marc Wirden,A. Tounkara,H. A. Traore,Vincent Cálvez,Anne‐Geneviève Marcelin,Sidonie Lambert-Niclot	2013	6
18	Pulmonary manifestations of human herpesvirus-8 during HIV infection European Respiratory Journal ·Raphaël Borie,Jacquès Cadranel,Amélie Guihot,Anne‐Geneviève Marcelin,Lionel Galicier,Louis‐Jean Couderc	2013	21
19	International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase Antimicrobial Agents and Chemotherapy ·Philip Grant,Jonathan Taylor,Andrew Nevins,Vincent Cálvez,Anne‐Geneviève Marcelin,Marc Wirden,Andrew Zolopa	2010	9
20	HHV8, maladie de Kaposi et transplantation d’organe : devrions-nous procéder à un dépistage ? Virologie ·Anne‐Geneviève Marcelin	2007	0

About Anne‐Geneviève Marcelin

Anne‐Geneviève Marcelin is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 364 papers that have together received 8.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (235 papers), HIV/AIDS drug development and treatment (225 papers), HIV/AIDS Research and Interventions (147 papers), Viral-associated cancers and disorders (48 papers), Cytomegalovirus and herpesvirus research (43 papers), Biochemical and Molecular Research (30 papers), SARS-CoV-2 and COVID-19 Research (28 papers) and Hepatitis C virus research (25 papers). The work is most often cited by research in Virology (5.3k citations), Infectious Diseases (6.3k citations) and Emergency Medicine (649 citations). Anne‐Geneviève Marcelin has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Vincent Cálvez, Christine Katlama, Marc Wirden, Gilles Peytavin, Isabelle Malet, Cathia Soulié, Roland Tubiana, Dominique Costagliola, Sidonie Lambert-Niclot and Anne Simon. Their work appears in journals such as Nucleic Acids Research, Angewandte Chemie International Edition and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact